Resolving lipoxin A4: Endogenous mediator or exogenous anti-inflammatory agent?
Saved in:
| Main Authors: | Reagan M. McGuffee, Matthew A. Luetzen, David A. Ford |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Journal of Lipid Research |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227524002396 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipoxin and Aspirin-Triggered Lipoxins
by: Mario Romano
Published: (2010-01-01) -
Lipoxin A4 yields an electrophilic 15-oxo metabolite that mediates FPR2 receptor-independent anti-inflammatory signaling
by: Adolf Koudelka, et al.
Published: (2025-01-01) -
Utilization of lipoxins and other specialised pro-resolving mediators in the prevention and treatment of diabetic nephropathy and diabetic cardiovascular disease
by: Bergo Ivan, et al.
Published: (2024-12-01) -
Lipoxin Receptors
by: Mario Romano, et al.
Published: (2007-01-01) -
IMMUNOMODULATORS OF ENDOGENOUS AND EXOGENOUS NATURE
by: Article Editorial
Published: (2015-06-01)